Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

GLFD

Guilford (GLFD)

Guilford Pharmaceuticals (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GLFD
FechaHoraFuenteTítuloSímboloCompañía
29/09/200517:27PR Newswire (US)Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA MergerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/09/200506:00Business WireMGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting PeriodNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200509:11PR Newswire (US)Guilford Pharmaceuticals Reports 2005 Second Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200507:45PR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
24/05/200514:44PR Newswire (US)Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/05/200514:00PR Newswire (US)Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCONASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/05/200514:39PR Newswire (US)Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant GliomaNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/05/200510:01PR Newswire (US)AGGRASTAT(R) Injection Strategy Trial Data Published in JAMANASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200508:42PR Newswire (US)Guilford Pharmaceuticals Reports 2005 First Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200507:45PR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
21/04/200513:07PR Newswire (US)Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development ProgramNASDAQ:GLFDGuilford Pharmaceuticals (MM)
06/04/200507:45PR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
24/03/200511:04PR Newswire (US)Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary EndpointNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/03/200510:03PR Newswire (US)Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200514:55PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Year-End Financial ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200506:45PR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/12/200416:30PR Newswire (US)Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net ProceedsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/12/200407:45PR Newswire (US)Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) ProNASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/11/200408:03PR Newswire (US)Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/11/200416:30PR Newswire (US)Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ RulesNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/11/200407:01PR Newswire (US)Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford PharmaceuticalsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
12/11/200409:58PR Newswire (US)AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/11/200411:11PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Third Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/11/200407:30PR Newswire (US)Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004NASDAQ:GLFDGuilford Pharmaceuticals (MM)
27/09/200409:33PR Newswire (US)Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends UntilNASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/09/200409:03PR Newswire (US)Guilford to Present at UBS Global Life Sciences ConferenceNASDAQ:GLFDGuilford Pharmaceuticals (MM)
20/09/200410:05PR Newswire (US)Guilford Pharmaceuticals Begins Phase III Clinical Trials of AQUAVAN(R) InjectionNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/09/200409:00PR Newswire (US)Guilford Pharmaceuticals Receives $6 Million For Rights to Polymer Drug Delivery PatentsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
14/09/200412:00PR Newswire (US)Guilford Pharmaceuticals Receives European Marketing Authorization for Expanded Use of GLIADEL(R) WaferNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/09/200408:58PR Newswire (US)Guilford Pharmaceuticals Announces Craig R. Smith, M.D. Will Retire as Chairman, President and Chief Executive OfficerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:GLFD